Denosumab in postmenopausal women with low bone mineral density

被引：2
|
作者：
Charles L. Loprinzi
机构：
来源：
Current Oncology Reports | 2006年 / 8卷 / 4期
关键词：
Bone Mineral Density; Alendronate; Distal Radius; Denosumab; Lumbosacral Spine;
D O I：
10.1007/s11912-006-0031-7
中图分类号：
学科分类号：
摘要：
This study demonstrated that various doses of denosumab, given subcutaneously at 3- or 6-month intervals, were well tolerated, markedly reduced measures of bone turnover, and led to improvements in bone densities at the lumbosacral spine, hip, and distal radius.
引用
收藏
页码：267 / 268
页数：1
相关论文
共 50 条
  • [1] Denosumab in postmenopausal women with low bone mineral density
    McClung, MR
    Lewiecki, EM
    Cohen, SB
    Bolognese, MA
    Woodson, GC
    Moffett, AH
    Peacock, M
    Miller, PD
    Lederman, SN
    Chesnut, CH
    Lain, D
    Kivitz, AJ
    Holloway, DL
    Zhang, C
    Peterson, MC
    Bekker, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08): : 821 - 831
  • [2] Denosumab in postmenopausal women with low bone mineral density
    Schwartzman, Julie
    Yazici, Yusuf
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22): : 2390 - 2390
  • [3] DENOSUMAB DECREASES CORTICAL POROSITY IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Zebaze, R. M.
    Boyd, S. K.
    Nishiyama, K. K.
    Hanley, D. A.
    Zanchetta, J. R.
    Thomas, T.
    Boutroy, S.
    Bogado, C.
    Austin, M.
    Libanati, C.
    Seeman, E.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S527 - S527
  • [4] Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
    Chen, Yi
    Zhu, Jun
    Zhou, Yiqin
    Peng, Jinhui
    Wang, Bo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] Denosumab Decreases Cortical Porosity in Postmenopausal Women with Low Bone Mineral Density
    Libanati, C.
    Boyd, S. K.
    Nishiyama, K. K.
    Zebaze, R. M.
    Hanley, D. A.
    Zanchetta, J. R.
    Thomas, Thierry
    Boutroy, S.
    Bogado, C. E.
    Austin, M.
    Seeman, E.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S637 - S638
  • [6] Effects of denosumab on bone mineral density and bone turnover in postmenopausal women
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Wang, Huei
    Liu, Yu
    Martin, Javier San
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06): : 2149 - 2157
  • [7] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
    Wensel, Terri M.
    Iranikhah, Maryam M.
    Wilborn, Teresa W.
    PHARMACOTHERAPY, 2011, 31 (05): : 510 - 523
  • [8] Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis
    Zhou, Zhenyu
    Chen, Chen
    Zhang, Jun
    Ji, Xinran
    Liu, Lifeng
    Zhang, Guichun
    Cao, Xuecheng
    Wang, Pingshan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (05): : 2113 - 2122
  • [9] DENOSUMAB FOLLOWING LONG-TERM ALENDRONATE IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Kendler, David L.
    Roux, Christian
    Benhamou, Claude-Laurent
    Brown, Jacques P.
    Lillestol, Mike
    Siddhanti, Suresh
    Man, Hoi-Shen
    San Martin, Javier
    Bone, Henry G.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S215 - S215
  • [10] Early Effects of Denosumab in Postmenopausal Women with Low Bone Mineral Density Previously Treated with Alendronate
    Brown, J. P.
    Kendler, D. L.
    Benhamou, C. L.
    Lillestol, M.
    Roux, C.
    Siddhanti, S.
    Man, H. S.
    Martin, J. San
    Bone, H. G.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3973 - 3974
12345